ライフサイエンスコーパス: leucine-rich

1 Leucine-rich alpha-2 glycoprotein (LRG) is a novel acute

2 Here, we investigated the role of leucine-rich alpha-2-glycoprotein 1 (LRG1) in normal and

3 LRG1 (leucine-rich-alpha2 glycoprotein 1) is known to regulate

4 d rate of enamel regeneration and the use of leucine-rich amelogenin peptide (LRAP), a nonphosphoryla

5 the activation of nucleotide binding domain, leucine-rich-containing family, pyrin domain containing

6 The innate immune cell sensor leucine-rich-containing family, pyrin domain containing

7 -alpha; IFN-beta; nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-

8 vated receptor 2, nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-

9 vated receptor 2, nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-

10 embrane models that were prone to generating leucine-rich designs.

11 In this study, we report that the leucine-rich domain (LRD) of neurofibromin inhibits inva

12 -specific tRNA binding protein that inhibits leucine-rich ETC complexes.

13 eukin-18 (IL-18), nucleotide-binding domain, leucine rich family (NLR) pyrin domain containing 3 (NLR

14 ibromodulin (Fmod) are subtypes of the small leucine-rich family of proteoglycans (SLRP).

15 The leucine-rich G protein-coupled receptor-5 (LGR5) is expr

16 Autoantibodies against leucine-rich glioma inactivated 1 (LGI1) are found in pa

17 d potassium channel (VGKC) complex proteins, leucine-rich glioma-inactivated 1 (LGI1) and contactin-a

18 s, which target the extracellular domains of leucine-rich glioma-inactivated 1 (LGI1) and contactin-a

19 auditory features results from mutations in leucine-rich glioma-inactivated 1 (LGI1), a soluble glyc

20 potassium channel-complex related proteins (leucine-rich glioma-inactivated 1 and contactin-associat

21 iallelic loss-of-function mutations in LGI4 (leucine-rich glioma-inactivated 4).

22 0.7%) had VGKCc (4 of whom were positive for leucine-rich glioma-inactivated protein 1 [LGI1] Ab), an

23 Leucine-rich glioma-inactivated1 (LGI1) encephalitis is

24 Limbic encephalitis with leucine-rich, glioma-inactivated 1 (LGI1) antibodies is

25 sistant seizures are common in patients with leucine-rich, glioma-inactivated 1 (LGI1)-IgG associated

26 ed with the potassium channel, in particular leucine-rich, glioma-inactivated protein 1 (LGI1) and co

27 te-receptor-antibody (pCSF(NMDAR), n = 7) or Leucine-rich-glioma-inactivated-1-Ab (pCSF(LGI1), n = 6)

28 cts with several short motifs, named helical leucine-rich motifs (HLMs), spread in the long C-termina

29 y through the activity of Rev's prototypical leucine-rich nuclear export signal (NES).

30 BEX3 possess a conserved leucine-rich nuclear export signal and experimental data

31 Prp40 possesses two leucine-rich nuclear export signals, but little is known

32 Here, we found that Drosophila leucine-rich pentatricopeptide repeat domain-containing

33 minant negative binder of Beclin-1, known as leucine-rich pentatricopeptide repeat-containing protein

34 n as candidate substrates of mOGT, including leucine-rich PPR-containing protein and mitochondrial ac

35 smic localization of proline, glutamic acid, leucine-rich protein 1 (PELP1) is observed in approximat

36 and the MAX2 (MORE AXILLARY GROWTH 2) F-box leucine-rich protein, which together perceive karrikins

37 Lumican, a small leucine rich proteoglycan (SLRP), is a component of extr

38 Decorin (DCN) is a small-leucine rich proteoglycan that mediates collagen fibrill

39 ent for glycoproteins, peptides of the small leucine-rich proteoglycan decorin were identified consis

40 cal, but unconnected, functions of the small leucine-rich proteoglycan, decorin.

41 Decorin, an archetypical small leucine-rich proteoglycan, initiates a protracted autoph

42 While the small leucine rich proteoglycans (SLRPs), including decorin an

43 e to salicylic acid (SA), and protein kinase leucine-rich receptors (PK-LRR).

44 cleotide variant (SNV) within the C-terminal leucine rich repeat (LRR) domain is responsible for the

45 The cytosolic nucleotide binding site-leucine rich repeat (NBS-LRR) resistance proteins of pla

46 ous work has shown that Elfn1 (extracellular leucine rich repeat and fibronectin Type III domain cont

47 s nucleotide-binding oligomerization domain, leucine rich repeat and pyrin domain containing 1 (NLRP1

48 orrelated with reduced expression of LRRC26 (leucine rich repeat containing 26), the gamma subunit ma

49 d activation of pathways of beta-catenin and leucine rich repeat containing G protein-coupled recepto

50 Nucleotide-binding oligomerization domain, leucine rich repeat containing X1 (NLRX1) is a unique NL

51 Both possess conserved leucine rich repeat domains (LRR) as proposed sites of m

52 length, with the most significant being the leucine rich repeat gene, LRRC34 (p = 3.69 x 10(-18)).

53 Leucine rich repeat kinase 2 (LRRK2) is an enigmatic enz

54 Pase domain Ras of complex proteins (ROC) of leucine rich repeat kinase 2 (LRRK2) result in an abnorm

55 The LRRK2 gene, coding for leucine rich repeat kinase 2 (LRRK2), is a key player in

56 epigenetic regulation of nucleotide-binding leucine rich repeat or Nod-Like Receptor (NLR) genes as

57 Here, we show that leucine rich repeat receptor and nogo-interacting protei

58 Leucine rich repeat transmembrane (LRRTM) proteins are s

59 a domain swap and point mutations, that the leucine-rich repeat (LRR) 5 region comprises an importan

60 We recently identified the leucine-rich repeat (LRR) adhesion protein, trophoblast

61 most N-terminal domain of Reck binds to the leucine-rich repeat (LRR) and immunoglobulin (Ig) domain

62 All sera and 9/11 CSFs bound both the leucine-rich repeat (LRR) and the epitempin repeat (EPTP

63 SHR4z has significant homology to the short leucine-rich repeat (LRR) domain of SOMATIC EMBRYOGENESI

64 In addition to its leucine-rich repeat (LRR) domain that has been previousl

65 is repressed by a flanking substrate-binding leucine-rich repeat (LRR) domain when substrate is absen

66 Leucine-rich repeat (LRR) domains are evolutionarily con

67 PI)-ANCHORED PROTEINS (LLG) complexes, or by leucine-rich repeat (LRR) extensin proteins (LRXs).

68 In particular, leucine-rich repeat (LRR) genes make the largest contrib

69 CCR4s contain N-terminal leucine-rich repeat (LRR) motifs that interact with CAF1

70 As proof-of-concept, we used a leucine-rich repeat (LRR) protein binder, called a repeb

71 Plant nucleotide-binding (NB) leucine-rich repeat (LRR) receptor (NLR) proteins functi

72 mutants encodes a receptor lacking a single leucine-rich repeat (LRR) within its N-terminus.

73 The nucleotide-binding-domain (NBD)-and leucine-rich repeat (LRR)-containing (NLR) family, pyrin

74 n in the nucleotide-binding domain (NBD) and leucine-rich repeat (LRR)-containing (NLR) inflammasome

75 his study, we identified LRRC25, a member of leucine-rich repeat (LRR)-containing protein family, as

76 subgroup of nucleotide-binding domain (NBD), leucine-rich repeat (LRR)-containing proteins (NLRs) att

77 ated promoter::GUS transgenic plants for all leucine-rich repeat (LRR)-RLKs in Arabidopsis and analyz

78 eotide-binding (NB) domain, and a C-terminal leucine-rich repeat (LRR).

79 Nucleotide-binding leucine-rich repeat (NB-LRR, or NLR) receptors mediate p

80 Plant nucleotide-binding leucine-rich repeat (NLR) disease resistance proteins re

81 NLRC4 [nucleotide-binding domain and leucine-rich repeat (NLR) family, caspase recruitment do

82 ost most of the conserved nucleotide-binding leucine-rich repeat (NLR) genes that are known to be inv

83 A nucleotide-binding, leucine-rich repeat (NLR) immune receptor gene was isola

84 Plant nucleotide-binding leucine-rich repeat (NLR) immune receptors activate cell

85 Plant nucleotide binding/leucine-rich repeat (NLR) immune receptors are activated

86 Nucleotide-binding leucine-rich repeat (NLR) immune receptors play a critic

87 Plant intracellular nucleotide binding leucine-rich repeat (NLR) immune receptors play critical

88 Plant nucleotide-binding leucine-rich repeat (NLR) immune receptors recognize pat

89 e of four genes encoding nucleotide-binding, leucine-rich repeat (NLR) immune receptors.

90 that are monitored by nucleotide-binding and leucine-rich repeat (NLR) immune receptors.

91 stance genes encoding nucleotide-binding and leucine-rich repeat (NLR) intracellular immune receptor

92 in the gene encoding the nucleotide binding, leucine-rich repeat (NLR) protein NbZAR1.

93 autoimmunity through the nucleotide-binding leucine-rich repeat (NLR) protein SUMM2 and the MAPK kin

94 ition of XopQ 1 (Roq1), a nucleotide-binding leucine-rich repeat (NLR) protein with a Toll-like inter

95 ical to VICTR, encoding a nucleotide-binding leucine-rich repeat (NLR) protein(3).

96 RPS5, a nucleotide-binding leucine-rich repeat (NLR) protein, is activated by the p

97 med RPS5, which encodes a nucleotide-binding leucine-rich repeat (NLR) protein.

98 Nucleotide-binding domain and leucine-rich repeat (NLR) proteins are well-known for th

99 Plant nucleotide-binding leucine-rich repeat (NLR) proteins enable the immune sys

100 Nucleotide-binding domain leucine-rich repeat (NLR) proteins function as cytosolic

101 Nucleotide binding site leucine-rich repeat (NLR) proteins of the plant innate i

102 Nucleotide-binding leucine-rich repeat (NLR) proteins play critical roles i

103 nce is often conferred by nucleotide-binding leucine-rich repeat (NLR) proteins, intracellular immune

104 nes encode intracellular nucleotide-binding, leucine-rich repeat (NLR) proteins.

105 ivation of the nucleotide-binding domain and leucine-rich repeat (NLR) pyrin family domain 3 (NLRP3)

106 coding a coiled-coil nucleotide binding site Leucine-rich repeat (NLR) receptor protein that was alte

107 ted by intracellular nucleotide-binding site leucine-rich repeat (NLR) receptor proteins.

108 Nucleotide-binding domain and leucine-rich repeat (NLR)-containing proteins in plants

109 OUS MIX2 (DM2) nucleotide-binding domain and leucine-rich repeat (NLR)-encoding locus in A. thaliana.

110 f TIR domain-containing, nucleotide binding, leucine-rich repeat (TNL) immune receptors.

111 NLR (nucleotide-binding [NB] leucine-rich repeat [LRR] receptor) proteins are critica

112 NLRs (nucleotide-binding domain [NBD] leucine-rich repeat [LRR]-containing proteins) exhibit d

113 o a pair of amino acids, 106 and 156, in the leucine-rich repeat and central domains and show these m

114 Leucine-rich repeat and Ig-like domain-containing Nogo r

115 We previously demonstrated that leucine-rich repeat and Ig-like domain-containing Nogo r

116 d nucleotide-binding oligomerization domain, leucine-rich repeat and pyrin domain containing 3 (NRLP3

117 ng and oligomerization domain-like receptor, leucine-rich repeat and pyrin domain-containing 3 (NLRP3

118 nase kinases (MKKs) and rodent NLRP1B (NACHT leucine-rich repeat and pyrin domain-containing protein

119 ate mapping of nucleotide-binding domain and leucine-rich repeat containing (NLR) genes.

120 VASP, extended-synaptotagmin 2 [ESYT2], and leucine-rich repeat containing 15 [LRRC15]), and "isomer

121 nical events except stroke, the LRRC3B gene (leucine-rich repeat containing 3B) with myocardial infar

122 Leucine-rich repeat containing 8A (LRRC8A) is an ubiquit

123 Here, we report that the leucine-rich repeat containing family 8 (LRRC8)/volume-r

124 aR1 as a stereoselective activator for human leucine-rich repeat containing G protein-coupled recepto

125 Leucine-rich repeat containing G-protein-coupled recepto

126 tly characterized nucleotide-binding domain, leucine-rich repeat containing protein (NLR) that negati

127 Here, we report that leucine-rich repeat containing protein 25 (LRRC25) is a

128 xplore the role of nucleotide-binding domain leucine-rich repeat containing receptor family member NL

129 re the role of the nucleotide-binding domain leucine-rich repeat containing receptor family member Nl

130 he role of the nucleotide-binding domain and leucine-rich repeat containing receptor NLRP10 in diseas

131 Nucleotide-binding, leucine-rich repeat containing X1 (NLRX1) is a mitochond

132 Five nucleotide binding leucine-rich repeat contigs distinguished resistant and

133 1 component (S519C16) of S519 with the first leucine-rich repeat domain (L1) of the insulin receptor.

134 alpha dissociation and unfolds the GPIbalpha leucine-rich repeat domain (LRRD) and juxtamembrane mech

135 Scribble consists of a leucine-rich repeat domain and four PDZ domains, with th

136 The tyrosine-sulfated domain and the leucine-rich repeat domain both bound to three specific

137 n asymmetric dimer bridged by the N-terminal leucine-rich repeat domain of ANP32A.

138 nt interface specifically formed between the leucine-rich repeat domain of FBXL2 and PTAR1, which unm

139 tartan (trn), which encodes a transmembrane leucine-rich repeat domain protein that mediates cell-ce

140 domain gene product containing an N-terminal leucine-rich repeat domain, followed by a likely posttra

141 this study, we show that Scrib, through its leucine-rich repeat domain, forms a complex in vivo with

142 e plant can evolve nucleotide-binding domain-leucine-rich repeat domain-containing proteins to recogn

143 Receptor kinases with extracellular leucine-rich repeat domains (LRR-RKs) form the largest g

144 Nucleotide binding- and leucine-rich repeat domains of NLRC4, but not its CARD,

145 Moreover, the leucine-rich repeat domains, and specifically four amino

146 in NLRP1, encoding Nucleotide-Binding Domain Leucine-Rich Repeat Family Pyrin Domain-Containing 1.

147 hibitor Flightless-1 and its binding partner leucine-rich repeat flightless-interacting protein 2.

148 We show that Drosophila leucine-rich repeat G protein-coupled receptor 3 (Lgr3)

149 d genes included 639 nucleotide-binding site leucine-rich repeat genes (NBS-LRRs), 290 receptor-like

150 and 56% (343) of 616 nucleotide-binding site-leucine-rich repeat genes harbored at least one Tnt1 ins

151 Nucleotide-binding and leucine-rich repeat immune receptors (NLRs) provide resi

152 ponse proteins, including nucleotide-binding leucine-rich repeat immune receptors, oxidative and DNA

153 The leucine-rich repeat kinase (LRRK)-2 protein contains non

154 Mutations in leucine-rich repeat kinase 2 (LRRK2) and alpha-synuclein

155 Mutations in the gene encoding for leucine-rich repeat kinase 2 (LRRK2) are a common cause

156 Mutations in leucine-rich repeat kinase 2 (LRRK2) are associated with

157 Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common

158 Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common

159 Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common

160 Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most freque

161 Mutations in leucine-rich repeat kinase 2 (LRRK2) contribute to devel

162 Leucine-rich repeat kinase 2 (LRRK2) encodes a complex p

163 Leucine-rich repeat kinase 2 (LRRK2) G2019S is a relativ

164 Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are the most c

165 ortem PD patients' substantia nigra; and (b) leucine-rich repeat kinase 2 (LRRK2) gene identified pat

166 Genetic variation in the leucine-rich repeat kinase 2 (LRRK2) gene is associated

167 Leucine-rich repeat kinase 2 (LRRK2) has been linked to

168 The Parkinson's disease (PD)-associated gene leucine-rich repeat kinase 2 (LRRK2) has been studied ex

169 The G2019S mutation in leucine-rich repeat kinase 2 (LRRK2) is a common cause o

170 The G2019S mutation in leucine-rich repeat kinase 2 (LRRK2) is a common cause o

171 Leucine-rich repeat kinase 2 (LRRK2) is a large multidom

172 Leucine-rich repeat kinase 2 (LRRK2) is a large multidom

173 Leucine-rich repeat kinase 2 (LRRK2) is a large, multido

174 Leucine-rich repeat kinase 2 (LRRK2) is a promising ther

175 Leucine-rich repeat kinase 2 (LRRK2) is the most commonl

176 Mutations in leucine-rich repeat kinase 2 (LRRK2) lead to late-onset,

177 A broad role for leucine-rich repeat kinase 2 (LRRK2) mutations in famili

178 We investigated the role of leucine-rich repeat kinase 2 (LRRK2) on lysosome biology

179 We found that the Parkinson's disease gene, leucine-rich repeat kinase 2 (LRRK2), has an unexpected

180 unknown, but several genetic loci, including leucine-rich repeat kinase 2 (LRRK2), have been identifi

181 Mutations in leucine-rich repeat kinase 2 (LRRK2), such as G2019S, ar

182 1 exacerbated death of PQ-exposed cells in a leucine-rich repeat kinase 2-mediated manner.

183 Inhibition of leucine-rich repeat kinase using PFE360 failed to rescue

184 s a coiled-coil, nucleotide-binding site and leucine-rich repeat protein (CNL).

185 Ptr1 candidates to eight nucleotide-binding leucine-rich repeat protein (NLR)-encoding genes.

186 r matrix component proline/arginine-rich end leucine-rich repeat protein (PRELP) is a novel antibacte

187 he EMT inducer Twist1 by enhancing F-box and leucine-rich repeat protein 14 (FBXL14)-mediated polyubi

188 F-box and leucine-rich repeat protein 16 (FBXL16) is a poorly stud

189 Here, we show that Fbxl17 (F-box and leucine-rich repeat protein 17) targets Sufu for proteol

190 ISLR2 (immunoglobulin superfamily containing leucine-rich repeat protein 2) and STRA6 (stimulated by

191 is capable of triggering NLRP3 (NLR-family, leucine-rich repeat protein 3) inflammasome activation a

192 usly unrecognized role for the transmembrane leucine-rich repeat protein Lapsyn in regulating mng dev

193 We show that the phosphatase PH domain leucine-rich repeat protein phosphatase (PHLPP) downstre

194 n this study, we demonstrated that PH domain leucine-rich repeat protein phosphatase (PHLPP), a novel

195 we identified pleckstrin homology domain and leucine-rich repeat protein phosphatase 1 (PHLPP1) as a

196 that deletion of the gene encoding PH domain Leucine-rich repeat Protein Phosphatase 1 (PHLPP1) prote

197 Pleckstrin homology (PH) domain and leucine-rich repeat protein phosphatase 1 (Phlpp1) regul

198 iled multi-genome-derived nucleotide-binding leucine-rich repeat protein repertoire involved in disea

199 1.2 encodes a coiled-coil nucleotide-binding leucine-rich repeat protein that in addition to potato a

200 rice gene Xa1, encoding a nucleotide-binding leucine-rich repeat protein, confers resistance against

201 rod bipolar cell terminals is regulated by a leucine-rich repeat protein, LRRTM4.

202 c map of the entire folding landscape of the leucine-rich repeat protein, pp32 (Anp32), obtained by c

203 Nucleotide binding domain and leucine-rich repeat proteins (NLRs) are important recept

204 enes encoding coiled-coil nucleotide-binding leucine-rich repeat proteins designated CNL3 and CNL13.

205 ns, immunoglobulin superfamily proteins, and leucine-rich repeat proteins, as well as their associate

206 and activate the nucleotide-binding domain, leucine-rich repeat pyrin domain-containing 3 (NLRP3) in

207 ovo assembly of complete nucleotide-binding, leucine-rich repeat receptor (NLR) genes, their regulato

208 Floral abscission is controlled by the leucine-rich repeat receptor kinase (LRR-RK) HAESA and t

209 The leucine-rich repeat receptor kinases (LRR-RK) FLS2 and E

210 Plants use leucine-rich repeat receptor kinases (LRR-RKs) to sense

211 by direct binding to the membrane-localized leucine-rich repeat receptor kinases, PEP RECEPTOR1 (PEP

212 ant responses, we identified a corresponding leucine-rich repeat receptor, termed INR, specific to se

213 roid insensitive 1 (BRI1) is a member of the leucine-rich repeat receptor-like kinase family.

214 SCM, a leucine-rich repeat receptor-like kinase, is required fo

215 st to G protein activation in animals, plant leucine-rich repeat receptor-like kinases (LRR RLKs), no

216 nases expanded massively in land plants, and leucine-rich repeat receptor-like kinases (LRR-RLK) cons

217 Cell signaling pathways mediated by leucine-rich repeat receptor-like kinases (LRR-RLKs) are

218 In embryophytes, the leucine-rich repeat receptor-like kinases (LRR-RLKs) are

219 Both pathways involve leucine-rich repeat receptor-like kinases acting in shoo

220 Nucleotide-binding leucine-rich repeat receptors (NLRs) monitor the plant i

221 ction using intracellular nucleotide-binding leucine-rich repeat receptors (NLRs) that directly or in

222 innate immunity relies on nucleotide binding leucine-rich repeat receptors (NLRs) that recognize path

223 i, including proteins putatively involved in leucine-rich repeat recognition activity, second messeng

224 Nucleotide-binding site leucine-rich repeat resistance genes (NLRs) allow plants

225 ike mechanism that employs flanking variable leucine-rich repeat sequences as templates in associatio

226 cluding genes putatively encoding NB-ARC and leucine-rich repeat sequences, protein kinases and defen

227 PR library targeting the immunity-associated leucine-rich repeat subfamily XII genes, heritable mutat

228 members of the immunoglobulin, cadherin, and leucine-rich repeat superfamilies.

229 ds to two transcellular ligands: fibronectin leucine-rich repeat transmembrane proteins (FLRTs) and t

230 rs designated "nucleotide-binding domain and leucine-rich repeat" (NLR) proteins that translate patho

231 ere, we show that nucleotide-binding domain, leucine-rich repeat, and pyrin domain-containing protein

232 , nucleotide-binding oligomerization domain, leucine-rich repeat, and pyrin protein 3 complex, CASP1,

233 d nucleotide-binding oligomerization domain, leucine-rich repeat, and pyrin protein 3 complex.

234 LAT); B-cell CLL/lymphoma 11B (BCL11B); RGD, leucine-rich repeat, tropomodulin domain, and proline-ri

235 between 2 candidate genes, EMSY and LRRC32 (leucine-rich repeat-containing 32) but the functional me

236 (i.e. SEC61) and ER proteins (ribophorin I, leucine-rich repeat-containing 59 (LRRC59), and SEC62) p

237 ly defined, revealing that it belongs to the leucine-rich repeat-containing 8 (LRRC8) protein family.

238 The recent identification of Leucine-Rich Repeat-Containing 8 (LRRC8A-E) proteins as

239 In mice, specific nucleotide-binding domain, leucine-rich repeat-containing family, apoptosis inhibit

240 IPs) activate the nucleotide-binding domain, leucine-rich repeat-containing family, CARD domain-conta

241 , we report a pivotal role for the R-spondin/leucine-rich repeat-containing G protein-coupled recepto

242 Leucine-rich repeat-containing G protein-coupled recepto

243 rkers, epithelial cell adhesion molecule and leucine-rich repeat-containing G protein-coupled recepto

244 lycan motif common to all bacteria, supports leucine-rich repeat-containing G protein-coupled recepto

245 Human organoids derived from leucine-rich repeat-containing G protein-coupled recepto

246 WNT/beta-catenin signaling in cells lacking leucine-rich repeat-containing G-protein coupled recepto

247 ciated CpG was cg03566881 located within the leucine-rich repeat-containing G-protein coupled recepto

248 ified Wnt environment leads to activation of leucine-rich repeat-containing G-protein coupled recepto

249 Leucine-rich repeat-containing G-protein coupled recepto

250 inct molecular markers, including Norrin and leucine-rich repeat-containing G-protein-coupled recepto

251 Here we show that the leucine-rich repeat-containing G-protein-coupled recepto

252 Herein we report that leucine-rich repeat-containing G-protein-coupled recepto

253 R-spondins (Rspos) are endogenous ligands of leucine-rich repeat-containing G-protein-coupled recepto

254 through the transcriptional up-regulation of leucine-rich repeat-containing GPCR 4 (Lgr4).

255 The fourth member of the leucine-rich repeat-containing GPCR family (LGR4, freque

256 o the B-family (or secretin-like), and 2 are leucine-rich repeat-containing GPCRs.

257 d nucleotide-binding oligomerization domain, leucine-rich repeat-containing protein (NLRP) 3 and pro-

258 Here, we report a DNA repair suppressor, leucine-rich repeat-containing protein 31 (LRRC31), that

259 These channels are formed by leucine-rich repeat-containing protein 8 (LRRC8) family

260 ator of reactive oxygen species (NRROS) is a leucine-rich repeat-containing protein that uniquely ass

261 are sensed by nucleotide binding domain and leucine-rich repeat-containing proteins (NLRs), which tr

262 Nucleotide-binding and leucine-rich repeat-containing receptors (NLRs) encompas

263 eotide-binding oligomerization domain (Nod), leucine-rich repeat-containing receptors (NLRs), and pyr

264 or cell surface molecules and identified the leucine-rich repeat-containing transmembrane protein kno

265 ionships between relaxin family peptides and leucine-rich repeat-containing, G protein-coupled recept

266 es with pyrin and nucleotide-binding domain, leucine-rich repeat/pyrin domain-containing 3.

267 I), an actin-binding protein that contains a leucine-rich-repeat (LRR), which binds R-ras and may reg

268 existing phytohormone and nucleotide-binding-leucine-rich-repeat (NLR) networks, to regulate immunity

269 ique among the nucleotide-binding-domain and leucine-rich-repeat (NLR) proteins in its mitochondrial

270 The earring-shaped NLRP3 consists of curved leucine-rich-repeat and globular NACHT domains, and the

271 tf13, defining it as an F-box protein of the leucine-rich-repeat family, and demonstrates how a novel

272 s in the expansion of nucleotide-binding and leucine-rich-repeat proteins (NLRs), the major disease-r

273 ts in Arabidopsis, and identified HPCA1 as a leucine-rich-repeat receptor kinase belonging to a previ

274 Here we demonstrate that the leucine-rich-repeat receptor Tartan and the teneurin Ten

275 Here we report FASCIATED EAR3 (FEA3), a leucine-rich-repeat receptor that functions in stem cell

276 s, RGF1 INSENSITIVEs (RGIs), a clade of five leucine-rich-repeat receptor-like kinases, in promoting

277 The NLRs or NBS-LRRs (nucleotide-binding, leucine-rich-repeat) form the largest resistance gene fa

278 eptor-related alpha, flightless-1 (FLII) and leucine-rich-repeat-(in FLII)-interacting-protein-1 as a

279 the contributions of two recently identified leucine-rich-repeat-containing (LRRC) regulatory gamma s

280 Pm5e encodes a nucleotide-binding domain leucine-rich-repeat-containing (NLR) protein.

281 st these factors using mutant LRRK2(R1441G) (leucine-rich-repeat-kinase-2) knockin mice.

282 Nucleotide binding site-leucine rich repeats (NLRs), receptor-like kinases (RLKs

283 h NLRP10 is the only NLR protein lacking the leucine rich repeats, it has been implicated in multiple

284 Herein, we introduce leucine-rich repeats (LRRs) and calponin homology contai

285 scaffold protein composed almost entirely by leucine-rich repeats (LRRs) and having an N-terminal reg

286 c screen for genes encoding proteins bearing leucine-rich repeats (LRRs) and nucleotide-binding domai

287 usly expressed transmembrane protein with 17 leucine-rich repeats (LRRs) at its C-terminal end and is

288 with its substrate C-MYC via its C-terminal leucine-rich repeats (LRRs) domain.

289 ses an additional 33 amino acids between the leucine-rich repeats and carboxy-terminal low-complexity

290 tion is linked to carcinogenesis, and Lrig1 (leucine-rich repeats and Ig-like domains 1) marks a dist

291 (CITA), NLRC5 [nucleotide-binding domain and leucine-rich repeats containing (NLR) family, caspase ac

292 hocyte receptors (VLRs) composed of variable leucine-rich repeats, which are differentially expressed

293 ng on the NLRX1 (nucleotide-binding, lots of leucine-rich repeats-containing protein member X1)-TUFM

294 domain, and a variable number of C-terminal leucine-rich repeats.

295 ibited by intramolecular binding to the Vms1 leucine-rich sequence (LRS).

296 also found that Lys-714 was located within a leucine-rich stretch, which resembles a nuclear export s

297 by distinct pathways downstream of the DMA-1 leucine-rich transmembrane (LRR-TM) receptor.

298 Here, we determined that fibronectin leucine-rich transmembrane protein 2 (FLRT2), a repulsiv

299 eurons in Caenorhabditis elegans through the leucine-rich transmembrane receptor DMA-1/LRR-TM express

300 repeats of thermophilic HEAT (PBS_HEAT) and Leucine-Rich Variant (LRV) structural motifs, respective